1. Home
  2. PROF vs ARCT Comparison

PROF vs ARCT Comparison

Compare PROF & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Profound Medical Corp.

PROF

Profound Medical Corp.

HOLD

Current Price

$6.80

Market Cap

247.5M

Sector

Health Care

ML Signal

HOLD

Logo Arcturus Therapeutics Holdings Inc.

ARCT

Arcturus Therapeutics Holdings Inc.

HOLD

Current Price

$6.19

Market Cap

198.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PROF
ARCT
Founded
N/A
2013
Country
Canada
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
247.5M
198.1M
IPO Year
2017
2019

Fundamental Metrics

Financial Performance
Metric
PROF
ARCT
Price
$6.80
$6.19
Analyst Decision
Strong Buy
Buy
Analyst Count
1
10
Target Price
$12.00
$24.11
AVG Volume (30 Days)
75.8K
515.7K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
25.89
20.00
EPS
0.19
N/A
Revenue
$16,098,000.00
$82,031,000.00
Revenue This Year
$92.40
N/A
Revenue Next Year
$64.10
$12.77
P/E Ratio
$36.63
N/A
Revenue Growth
50.73
N/A
52 Week Low
$3.92
$5.85
52 Week High
$8.95
$24.14

Technical Indicators

Market Signals
Indicator
PROF
ARCT
Relative Strength Index (RSI) 47.19 33.54
Support Level $6.43 $6.08
Resistance Level $7.06 $7.98
Average True Range (ATR) 0.38 0.47
MACD -0.01 -0.07
Stochastic Oscillator 31.75 9.50

Price Performance

Historical Comparison
PROF
ARCT

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.

Share on Social Networks: